<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03588429</url>
  </required_header>
  <id_info>
    <org_study_id>2018CZTCWM</org_study_id>
    <nct_id>NCT03588429</nct_id>
  </id_info>
  <brief_title>The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics</brief_title>
  <official_title>The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to evaluate the ratio of hypnotic to analgesic potency of
      sevoflurane and isoflurane at equi-minimum alveolar concentration using EEG analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anesthetic agents vary in their relative hypnotic potency. Recent studies demonstrated that
      equi-minimum alveolar concentration of various volatile anesthetic agents may produce
      different spectral entropy or bispectral index values. However, there is no study that
      demonstrate the difference between analgesic potency of volatile anesthetics. The aim of this
      clinical trial is to evaluate the ratio of hypnotic to analgesic potency of sevoflurane and
      isoflurane at equi-minimum alveolar concentration using EEG analysis.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Researchers go abroad to study
  </why_stopped>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>qCON index</measure>
    <time_frame>the 10 min at steady-state anesthesia after endotracheal intubation</time_frame>
    <description>The hypnotic potency of volatile anesthetics was evaluated by qCON index during standardized nociceptive stimulus (30 s, 50 mA, 50 Hz tetanic stimulation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>qNOX index</measure>
    <time_frame>the 10 min at steady-state anesthesia after endotracheal intubation</time_frame>
    <description>The analgesic potency of volatile anesthetics was evaluated by qNOX index during standardized nociceptive stimulus (30 s, 50 mA, 50 Hz tetanic stimulation).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia was maintained with sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia was maintained with isoflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Anesthesia was maintained with sevoflurane in patients undergoing standardized nociceptive stimulus (long-lasting tetanic stimulus of the ulnar nerve; 30 s, 50 mA, 50 Hz, square-wave).</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>SEVO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <description>Anesthesia was maintained with isoflurane in patients undergoing standardized nociceptive stimulus (long-lasting tetanic stimulus of the ulnar nerve; 30 s, 50 mA, 50 Hz, square-wave).</description>
    <arm_group_label>Isoflurane</arm_group_label>
    <other_name>ISO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing general anesthesia using volatile anesthetics and intubation

          -  patients with american society of anesthesiologist physical status I, II

          -  patients obtaining written informed consent

        Exclusion Criteria:

          -  patients with a history of any psychiatric or neurological disease

          -  patients who had received any medication affecting the central nervous system

          -  patients who had received medication affecting the sympathetic or parasympathetic
             nervous systems

          -  patients undergoing supraglottic airway for airway management

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruizhao Lv, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <zip>061001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 6, 2018</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>April 24, 2019</last_update_submitted>
  <last_update_submitted_qc>April 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sevoflurane</keyword>
  <keyword>Isoflurane</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

